The effect of brief exposure to chloramphenicol of a pathogenic strain of Escherichia coli on susceptibility to normal human leukocytes was examined. Leukocytes killed chloramphenicol-pretreated E. coli more efficiently than they did untreated controls. Phagocytosis of pretreated bacteria, as measured by the uptake of radiolabeled bacteria and by direct visual count of engulfed bacteria, was not significantly increased. The decrease in viability was associated with enhanced intracellular killing of phagocytosed antibiotic-damaged bacteria. Chloramphenicol pretreatment altered the frequency distribution of intracellular bacteria by decreasing the number of leukocytes containing multiple stainable bacteria. Leukocytes failed to kill chloramphenicol-pretreated E. coli in the presence of phenylbutazone, which allowed an accumulation of intracellular bacteria. These results indicate that exposure of E. coli to chloramphenicol renders the bacteria more susceptible to intracellular killing and degradation.
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Phagocytosis is the single most important activity contributing to host resistance to bacterial infection. Clinical experience has shown that, for antimicrobial chemotherapy to be effective, a functional host defense system is required. Methods of dosage determination based solely on achieving a greater-than-minimal inhibitory concentration (MIC) of drug at the site of infection take no account of the host's contribution to eradication of the pathogen. The presence of an antimicrobial agent may influence the in vivo interaction of the pathogen with the host's defense system. Several studies (1-3, 7, 16, 20, 24) have indicated that antibiotics enhance bacterial susceptibility to phagocytosis. An understanding of the interaction of antibiotic, bacterium, and the host's immune defense components should be useful in the determination of dosage schedules for both normal and immunodeficient patients.
In an earlier study (20) , we demonstrated that brief exposure to chloramphenicol enhanced susceptibility of E. coli to leukocytic activity in the period immediately following exposure of bacteria to antibiotic. In this study, we have investigated the effect of brief exposure to chloramphenicol on uptake and intracellular killing of bacteria by intact polymorphonuclear neutrophils (PMN).
MATERIALS AND METHODS
Test organism and culture conditions. E. coli U 2663, originally isolated from infected urine, was used as the test organism in all experiments. This strain was found to be resistant to lysis by pooled human serum and susceptible to chloramphenicol. The strain was maintained on nutrient agar slopes and subcultured every 2 weeks. In all experiments, cultures of the bacteria in the log phase of growth were obtained by dilution of an overnight culture grown in medium 199 (28) . The MIC of E. coli U 2663 was 6 ug of chloramphenicol per ml.
Leukocytes. Blood was drawn from a healthy volunteer who was not taking any medication, and the blood was promptly heparinized (10 U of heparin per ml of blood). To each 10 ml of heparinized blood, 3 ml of 6% dextran T70 (Pharmacia Fine Chemicals, Uppsala, Sweden) in normal saline was added, and the erythrocytes were allowed to sediment for 45 25 yg/ml. The dimethyl sulfoxide introduced into the experimental tubes had no effect on the viability of leukocytes or bacteria.
Trypan blue (BDH Chemicals Ltd., Poole, England) was dissolved in HBSS and filtered through a 0.45-,um filter. The stock solution (10 mg/ml) was added to the leukocyte suspension to give a final concentration of 1 mg/ml.
Iodoacetic acid (Sigma Chemical Co.) was dissolved in HBSS to give a 20 mM stock solution. The pH was adjusted to 7.4 with NaOH. A 0.1-ml amount of the stock solution was added to 0.9 ml of leukocyte suspension (5 x 106 PMN per ml), and the tubes were incubated for 25 min at 37°C. The leukocytes were washed once by centrifugation and resuspended to a concentration of 5 x 106/ml in heparinized medium 199.'
The inhibitors had no effect on the growth of E. coli in NHS or HHS during the experiment and were found not to be toxic to the PMN, as judged by the exclusion of trypan blue.
Determination of bacterial killing. Killing of antibiotic-pretreated bacteria by leukocytes was determined as described previously (20) . Briefly, logphase bacteria were incubated in chloramphenicol (24 jig/ml) or in medium 199 alone (control untreated bacteria) for 10 mim. The bacteria were washed with HBSS and resuspended in medium 199 to 5 x 107 bacteria per ml. Portions were added to a mixture of leukocytes (5 x 106/ml) and NHS (10%) in sterile plastic tubes. The ratio of bacteria to PMN in the experimental tubes was 1:1. All incubations and washings were carried out at 37°C. Controls were included in which HHS replaced NHS and from which leukocytes were omitted. At appropriate intervals, 20-p1 portions of the leukocyte-bacteria mixture were added to sterile distilled water. The leukocytes were disrupted by frequent vigorous agitation for 10 min. Portions (20 pd each) were spread onto nutrient agar, and the colonies were counted after overnight incubation at 37°C. Tests to determine the effect on bacteria of exposure to water showed no significant change in viability over at least 30 min of contact with water, and greater than 95% disruption of leukocytes was achieved.
Determination of leukocyte-associated bacteria and intracellular killing. The methods employed were essentially those of Peterson et al. (19) . Briefly, for the determination of total leukocyte-associated bacteria, 200-pl portions of incubation mixtures containing leukocytes and radiolabeled bacteria were added to ice-cold HBSS and centrifuged at 80 x g for 7 min at 4°C. The leukocyte pellets were washed a further two times in ice-cold HBSS. The final leukocyte pellets were disrupted by vigorous agitation in 0.5 ml of sterile distilled water for 30 min. Duplicate 200-pd portions were added to disposable scintillation vials to which 2.5 ml of scintillation fluid was added. Radioactivity was determined with a Searle Mark III liquid scintillation counter. Control tubes containing radiolabeled bacteria alone were assayed in parallel to determine non-leukocyte-associated sedimented radioactivity. To determine viable leukocyte-associated bacteria, 20 Al of the final lysed leukocyte pellets were plated in triplicate onto nutrient agar and incubated overnight at 37°C, and the colonies were counted. 
RESULTS
Enhanced killing of chloramphenicolpretreated E. coli; the effect of inhibitors of leukocyte activity. The effect of chloramphenicol pretreatment of E. coli on viability in the presence of leukocytes and NHS is shown in Table 1 . Prior exposure of E. coli to 4x the MIC of chloramphenicol inhibited growth in the presence of leukocytes compared with the untreated control (P < 0.001, by Student's t test). HHS did not support leukocytic killing of chloramphenicol-pretreated E. coli. The effect of various inhibitors of leukocytic activity is also outlined in Table 1 . Pretreated bacteria in the absence of inhibitors showed a mean reduction of -0.12 (logio). The viable counts in the presence of the inhibitors were not significantly different from the viable counts of the untreated control.
Kinetics of phagocytosis and intracellular killing ofE. coli Figure 1 shows the rate of phagocytosis of [methyl-3H]thymidine-labeled E. coli by normal leukocytes in the presence of NHS, HHS, and NHS containing phenylbutazone. Control tubes containing bacteria in the absence of leukocytes were included in these experiments, and the values obtained from these tubes were subtracted from the tubes containing leukocytes to compensate for non-leukocyte-associated bacteria.
The accumulation of radiolabeled bacteria by leukocytes in the presence of NHS was rapid. The rate and the extent of uptake of chloramphenicol-pretreated E. coli did not differ significantly from those of untreated bacteria. In the presence of HHS, levels of leukocyte-associated radiolabel were low, and at 30 min, they were less than 10% of the levels observed in the presence of NHS.
The rate of phagocytosis was significantly decreased in the presence of phenylbutazone. Pretreatment with chloramphenicol did not significantly alter the accumulation of radiolabel by phenylbutazone-inhibited leukocytes, and at 60 min, uptake was 20 to 30% of that observed in the drug-free system.
The change with time of viable leukocyteassociated E. coli is shown in Fig. 2 . Chloramphenicol-pretreated E. coli were rapidly phagocytosed by the leukocytes in the first 5 min of contact. However, over the next 15 min, the number of leukocyte-associated viable bacteria decreased rapidly, and at 20 min, the number was 7% of that in the control. This decrease occurred concurrently with an increase in total (radiolabeled) leukocyte-associated E. coli (Fig.   1) .
Phenylbutazone abolished the rapid intracellular killing of E. coli observed with pretreated bacteria. No decrease in viable leukocyte-associated untreated bacteria was observed in these experiments.
In Table 2 , a comparison is made of leukocyteassociated total and viable bacteria. The count of total (viable and nonviable) E. coli was calculated from the uptake of radiolabeled bacteria at 30 min. The ratio of viable to total "intracellular" E. coli was calculated for untreated and chloramphenicol-pretreated bacteria. Total uptake by leukocytes in the presence of NHS did not differ markedly between control and pretreated bacteria, both being approximately 10% of the initial viable count at the time of mixing of bacteria with leukocytes. The ratio of viable to total intracellular E. coli for control bacteria was 0.13, whereas the ratio for pretreated bacteria was 0.006. These results indicate that the number of leukocyte-associated pretreated E. coli killed was approximately 20 and control E. colig at each tlme were analyzed coli, and open symbols represent untreated E. coli.
for significance using a two-tailed test (23) . The points on the curves represent the means, toWhereas there were no significant differences at gether with the standard deviations, ofthree separate 5 and 15 min, at 25 min and thereafter, the experiments. bNumbers refer to the average of three experiments. 'Ratio -Viable leukocyte-associated E. col/Total leukocyte-mociated E. col.
previously reported the first study on the interaction of human leukocytes with E. coli that had been subjected to brief exposure to a high concentration of chloramphenicol (20) . In that study, as in this investigation, the procedures used ensured that the level of residual antibiotic after exposure ofthe bacteria was negligible (less than 1/200 of the MIC). Thus, the observed increase in susceptibility of the antibiotic-exposed bacteria to the activity of leukocytes cannot be attributed to residual antibiotic.
The decreased viability of chloramphenicolpretreated E. coli in the presence of leukocytes could not be attributed to increased phagocytosis. However, an early and rapid increase in intracellular killing of the antibiotic-damaged bacteria was demonstrated (Fig. 1) . The mechanisms of the augmented intracellular killing have not yet been elucidated. Involvement of oxygen-dependent bactericidal mechanism is indicated since the killing of antibiotic-pretreated bacteria is inhibited by phenylbutazone (Table 2 ). This drug is an inhibitor of oxidative metabolism (27) and causes a reduction in superoxide-dependent and myeloperoxidase-mediated bactericidal activities. Cytochalasin B also has an inhibitory effect on leukocidal activity against antibiotic-damaged bacteria. This drug has been reported to inhibit the tranalocation of myeloperoxidase-containing granules to the phagosomes of human neutrophils (18) , probably by the disruption of the contractile LEUKOCYTE KILLING OF E. COLI 949 microfilament system of the cell (30) . The inhibition of killing by these drugs may have been partially due, to a decrease in phagocytosis, since both are known to reduce phagocytosis by human leukocytes. (25, 31 trstructural changes have been demonstrated in chloramphenicol-exposed E. coli (11, 14) . In addition, Klainer and Russell (11) have demonstrgted the release of outer membrane lipopolysaccharide from log-phase E. coli by chloramphenicol treatment, analogous to the release of lipopolysaccharide from E. coli by the action of .thyleimintetraacetic acid (12) . Such treatment increaes bacterial susceptibility to complement (22) and other membrane-active agnts (15) . Smooth-rough mutations that lead to varying defects in lipopolysaccharide structure decreas resistance to phagocytosis (6, 13, 26) and to the bactericidal activity of extracts of leukocyte granules (21, 29) . Since the integrity of the outer membrane of gram-negative bacteria is important in protection against host factors, we postulate that the enhanced susceptibility of chloramphenicol-treated E. coli to intraleukocyte killing is a result of chloramphenicol-induced structural changes in the outer membrane of the bacteria.
Whereas killing of intracellular gram-negative bacteria occurs soon after internalization, extensive degradation is delayed (4, 5) . The differences in frequency distribution (Fig. 3) suggest that some degradation to a nonstainable state is occurring with chloramphenicol pretreatment. The effect of increased degradation would be (i) to decrease the percentage of PMN containing stainable bacteria, (ii) to shift the frequency distribution to the left, and (iii) to decrease the average number of intracellular bacteria per PMN. All of these effects are observed with pretreated bacteria after 25 mmn of incubation.
The possibility of intracellular multiplication cannot be ruled out. Hsu and Radcliffe (10) compared intracellular killing of virulent and avirulent strains of Salmonella typhimurium within the peritoneal macrophages of guinea pigs. The initial destruction of the avirulent strain was greater, but both virulent and avirulent strains that survived initial kill were capable of intracellular multiplication after prolonged incubation. Differential multiplication of intracellular antibiotic pretreated and untreated bacteria may occur, and if untreated bacteria are able to multiply intracellularly, an increase in intracellular bacteria with a skew in frequency distribution to the right would also occur.
Chloramphenicol is a widely used antimicrobial agent with a broad spectrum of activity and is thought to act by inhibition of extracellular bacteria. Our data suggest a further activity of chloramphenicol which may be of clinical significance. The nonlethal damage sustained by initial contact with the drug has now been shown to render the bacteria more susceptible to intracellular killing. This is an example of synergy between antibiotics and host components which may aid in evolving a more rational basis for determining antibiotic dosage regimens.
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